US Patent Issued to Synthekine on July 28 for "IL12RB2 binding molecules and methods of use" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,317, issued on July 28, was assigned to Synthekine Inc. (Menlo Park, Calif.).

"IL12RB2 binding molecules and methods of use" was invented by Sandro Vivona (Menlo Park, Calif.), Robert Kastelein (Menlo Park, Calif.), Deepti Rokkam (Menlo Park, Calif.) and Patrick J. Lupardus (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL12Rb2, compositions comprising such antibodies, and methods of use thereof."

The patent was filed on Aug. 5, 2021, under Application No. 18/017,...